Pamela Haley's Insider Trades & SAST Disclosures
Pamela Haley's most recent trade in Arcadia Biosciences Inc was a trade of 23,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 16, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Pamela Haley.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcadia Biosciences Inc | Pamela Haley | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2022 | 23,000 | 255,313 | - | - | Stock Option (right to buy) | |
| Arcadia Biosciences Inc | Pamela Haley | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.70 per share. | 01 Aug 2022 | 700 | 5,088 (0%) | 0% | 0.7 | 490 | Common Stock |
| Arcadia Biosciences Inc | Pamela Haley | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2022 | 50,000 | 232,313 | - | - | Stock Option (right to buy) | |
| Arcadia Biosciences Inc | Pamela Haley | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2022 | 38,000 | 232,313 | - | - | Stock Option (right to buy) | |
| Arcadia Biosciences Inc | Pamela Haley | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2021 | 85,000 | 144,313 | - | - | Stock Option (right to buy) | |
| Arcadia Biosciences Inc | Pamela Haley | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.16 per share. | 21 Jan 2021 | 700 | 2,638 (0%) | 0% | 3.2 | 2,212 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges